Collateralized transactions (Tables)
|
12 Months Ended |
Mar. 31, 2026 |
| Collateralized Transactions |
|
| Offsetting of the transactions in the consolidated balance sheets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
43,464 |
|
|
¥ |
4,656 |
|
|
¥ |
45,747 |
|
|
¥ |
2,347 |
|
Less: Amounts offset in the consolidated balance sheets (2) |
|
|
(29,459 |
) |
|
|
|
|
|
|
(29,459 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net amounts as reported on the face of the consolidated balance sheets (3) |
|
¥ |
14,005 |
|
|
¥ |
4,656 |
|
|
¥ |
16,288 |
|
|
¥ |
2,347 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Additional amounts not offset in the consolidated balance sheets (4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial instruments and non-cash collateral |
|
|
(13,422 |
) |
|
|
(2,941 |
) |
|
|
(13,800 |
) |
|
|
(2,162 |
) |
|
|
|
(3 |
) |
|
|
— |
|
|
|
(4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
580 |
|
|
¥ |
1,715 |
|
|
¥ |
2,484 |
|
|
¥ |
185 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
49,251 |
|
|
¥ |
4,336 |
|
|
¥ |
51,275 |
|
|
¥ |
2,953 |
|
Less: Amounts offset in the consolidated balance sheets (2) |
|
|
(36,041 |
) |
|
|
|
|
|
|
(36,041 |
) |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net amounts as reported on the face of the consolidated balance sheets (3) |
|
¥ |
13,210 |
|
|
¥ |
4,336 |
|
|
¥ |
15,234 |
|
|
¥ |
2,953 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Additional amounts not offset in the consolidated balance sheets (4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial instruments and non-cash collateral |
|
|
(12,493 |
) |
|
|
(2,635 |
) |
|
|
(13,670 |
) |
|
|
(2,645 |
) |
|
|
|
(5 |
) |
|
|
|
|
|
|
(27 |
) |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
712 |
|
|
¥ |
1,701 |
|
|
¥ |
1,537 |
|
|
¥ |
308 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1) |
Include all recognized balances irrespective of whether they are transacted under a master netting agreement or whether Nomura has obtained sufficient evidence of enforceability of the master netting agreement. Amounts include transactions carried at fair value through election of the fair value option. As of March 31, 2025, the gross balance of reverse repurchase agreements and repurchase agreements which were not transacted under master netting agreements or are documented under master netting agreements for which Nomura has not yet obtained sufficient evidence of enforceability amounted to ¥441 billion and ¥1,973 billion, respectively. As of March 31, 2025, the gross balance of securities borrowing transactions and securities lending transactions which were not transacted under master netting agreements or are documented under master netting agreements for which Nomura has not yet obtained sufficient evidence of enforceability amounted to ¥1,528 billion and ¥ 111 billion, respectively. As of March 31, 2026, the gross balance of reverse repurchase agreements and repurchase agreements which were not transacted under master netting agreements or are documented under master netting agreements for which Nomura has not yet obtained sufficient evidence of enforceability amounted to ¥ 458 billion and ¥ 895 billion, respectively. As of March 31, 2026, the gross balance of securities borrowing transactions and securities lending transactions which were not transacted under master netting agreements or are documented under master netting agreements for which Nomura has not yet obtained sufficient evidence of enforceability amounted to ¥ 1,532 billion and ¥ 151 billion, respectively. |
| (2) |
Represent amounts offset through counterparty netting under master netting or similar agreements for which Nomura has obtained sufficient evidence of enforceability in accordance with ASC 210-20. Amounts offset include transactions carried at fair value through election of the fair value option. |
| (3) |
Reverse repurchase agreements and securities borrowing transactions are reported within Collateralized agreements Securities purchased under agreements to resell and Collateralized agreements in the consolidated balance sheets, respectively. Repurchase agreements and securities lending transactions are reported within Securities sold under agreements to repurchase and in the consolidated balance sheets, respectively. Amounts reported under securities lending transactions also include transactions where Nomura lends securities and receives securities that can be sold or pledged as collateral. Nomura recognizes the securities received at fair value and a liability for the same amount, representing the obligation to return those securities. The securities received and the liability are reported within and in the consolidated balance sheets, respectively. |
| (4) |
Represent amounts which are not permitted to be offset on the face of the consolidated balance sheets in accordance with ASC 210-20 but which provide Nomura with the right of offset in the event of counterparty |
|
default. Amounts relating to agreements where Nomura has not yet obtained sufficient evidence of enforceability of such offsetting rights are excluded. |
|
| Maturity analysis of repurchase agreements and securities lending transactions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
19,523 |
|
|
¥ |
20,673 |
|
|
¥ |
2,466 |
|
|
¥ |
1,848 |
|
|
¥ |
1,237 |
|
|
¥ |
45,747 |
|
Securities lending transactions |
|
|
1,384 |
|
|
|
144 |
|
|
|
14 |
|
|
|
255 |
|
|
|
550 |
|
|
|
2,347 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total gross recognized liabilities (2) |
|
¥ |
20,907 |
|
|
¥ |
20,817 |
|
|
¥ |
2,480 |
|
|
¥ |
2,103 |
|
|
¥ |
1,787 |
|
|
¥ |
48,094 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
22,834 |
|
|
¥ |
23,656 |
|
|
¥ |
1,783 |
|
|
¥ |
1,411 |
|
|
¥ |
1,591 |
|
|
¥ |
51,275 |
|
Securities lending transactions |
|
|
1,660 |
|
|
|
146 |
|
|
|
46 |
|
|
|
482 |
|
|
|
619 |
|
|
|
2,953 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total gross recognized liabilities (2) |
|
¥ |
24,494 |
|
|
¥ |
23,802 |
|
|
¥ |
1,829 |
|
|
¥ |
1,893 |
|
|
¥ |
2,210 |
|
|
¥ |
54,228 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1) |
Open transactions do not have an explicit contractual maturity date and are terminable on demand by Nomura or the counterparty. |
| (2) |
Repurchase agreements and securities lending transactions are reported within Securities sold under agreements to repurchase and in the consolidated balance sheets, respectively. Amounts reported for securities lending transactions also include transactions where Nomura lends securities and receives securities that can be sold or pledged as collateral. Nomura recognizes the securities received at fair value and a liability for the same amount, representing the obligation to return those securities. The securities received and the liability are reported within and in the consolidated balance sheets, respectively. The total gross recognized liabilities reported for repurchase agreements and securities lending transactions are consistent with the total gross balances reported in the offsetting disclosures above. |
|
| Securities transferred in repurchase agreements and securities lending transactions |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
|
|
|
Equities and convertible securities |
|
¥ |
401 |
|
|
¥ |
1,734 |
|
|
¥ |
2,135 |
|
Japanese government, agency and municipal securities |
|
|
2,202 |
|
|
|
1 |
|
|
|
2,203 |
|
Foreign government, agency and municipal securities |
|
|
34,569 |
|
|
|
81 |
|
|
|
34,650 |
|
Bank and corporate debt securities |
|
|
3,881 |
|
|
|
369 |
|
|
|
4,250 |
|
Commercial mortgage-backed securities (“CMBS”) |
|
|
29 |
|
|
|
|
|
|
|
29 |
|
Residential mortgage-backed securities (“RMBS”) (1) |
|
|
4,466 |
|
|
|
|
|
|
|
4,466 |
|
Collateralized debt obligations (“CDOs”) and other |
|
|
177 |
|
|
|
|
|
|
|
177 |
|
Investment trust funds and other |
|
|
22 |
|
|
|
162 |
|
|
|
184 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total gross recognized liabilities (2) |
|
¥ |
45,747 |
|
|
¥ |
2,347 |
|
|
¥ |
48,094 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
|
|
|
Equities and convertible securities |
|
¥ |
442 |
|
|
¥ |
2,272 |
|
|
¥ |
2,714 |
|
Japanese government, agency and municipal securities |
|
|
3,061 |
|
|
|
163 |
|
|
|
3,224 |
|
Foreign government, agency and municipal securities |
|
|
38,182 |
|
|
|
182 |
|
|
|
38,364 |
|
Bank and corporate debt securities |
|
|
5,598 |
|
|
|
267 |
|
|
|
5,865 |
|
Commercial mortgage-backed securities (“CMBS”) |
|
|
— |
|
|
|
|
|
|
|
— |
|
Residential mortgage-backed securities (“RMBS”) (1) |
|
|
3,635 |
|
|
|
|
|
|
|
3,635 |
|
Collateralized debt obligations (“CDOs”) and other |
|
|
346 |
|
|
|
|
|
|
|
346 |
|
Investment trust funds and other |
|
|
11 |
|
|
|
69 |
|
|
|
80 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total gross recognized liabilities (2) |
|
¥ |
51,275 |
|
|
¥ |
2,953 |
|
|
¥ |
54,228 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1) |
Includes ¥3,586 billion of U.S. government sponsored agency mortgage pass through securities and collateralized mortgage obligations as of March 31, 2025. Includes ¥2,877 billion of U.S. government sponsored agency mortgage pass through securities and collateralized mortgage obligations as of March 31, 2026. |
| (2) |
Repurchase agreements and securities lending transactions are reported within Securities sold under agreements to repurchase and in the consolidated balance sheets, respectively. Amounts reported for securities lending transactions also include transactions where Nomura lends securities and receives securities that can be sold or pledged as collateral. Nomura recognizes the securities received at fair value and a liability for the same amount, representing the obligation to return those securities. The securities received and the liability are reported within and in the consolidated balance sheets, respectively. The total gross recognized liabilities reported for repurchase agreements and securities lending transactions are consistent with the total gross balances reported in the offsetting disclosures above. |
|
| Fair value of securities received as collateral available to sell or repledge |
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
The fair value of collateral received |
|
¥ |
64,853 |
|
|
¥ |
69,667 |
|
The portion of the above received that has been sold (as reported as short sales within Trading liabilities in the consolidated balance sheets) or repledged |
|
|
48,717 |
|
|
|
56,304 |
|
|
| Assets owned, pledged as collateral |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equities and convertible securities |
|
¥ |
326,398 |
|
|
¥ |
417,915 |
|
Government and government agency securities |
|
|
1,134,816 |
|
|
|
1,396,517 |
|
Bank and corporate debt securities |
|
|
86,034 |
|
|
|
123,674 |
|
Commercial mortgage-backed securities (“CMBS”) |
|
|
|
|
|
|
5,189 |
|
Residential mortgage-backed securities (“RMBS”) |
|
|
2,626,708 |
|
|
|
2,120,771 |
|
Collateralized debt obligations (“CDOs”) and other (1) |
|
|
12,391 |
|
|
|
7,864 |
|
Investment trust funds and other |
|
|
21,042 |
|
|
|
10,715 |
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
4,207,389 |
|
|
¥ |
4,082,645 |
|
|
|
|
|
|
|
|
|
|
Non-trading debt securities (2) |
|
|
15,896 |
|
|
|
21,566 |
|
Investments in and advances to affiliated companies (3) |
|
¥ |
16,124 |
|
|
¥ |
16,086 |
|
| (1) |
Includes collateralized loan obligations (“CLOs”) and asset-backed securities (“ABSs”) such as those secured on credit card loans, auto loans and student loans. |
| (2) |
Non-trading debt securities are primarily Japanese municipal securities issued by prefectures or ordinance-designated city. |
| (3) |
Investments in and advances to affiliated companies comprise shares in Nomura Research Institute, Ltd. |
|
| Assets subject to lien |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
627,090 |
|
|
¥ |
934,055 |
|
Trading assets and private equity and debt investments |
|
|
1,766,083 |
|
|
|
1,713,792 |
|
Office buildings, land, equipment and facilities |
|
|
2,933 |
|
|
|
13,617 |
|
Non-trading debt securities |
|
|
117,655 |
|
|
|
212,469 |
|
Investments in and advances to affiliated companies |
|
|
2 |
|
|
|
3 |
|
|
|
|
1,333 |
|
|
|
1,522 |
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
2,515,096 |
|
|
¥ |
2,875,458 |
|
|
|
|
|
|
|
|
|
|
|